Literature DB >> 18286542

The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice.

Panayotis K Thanos1, Michael Michaelides, Helene Benveniste, Gene Jack Wang, Nora D Volkow.   

Abstract

Cocaine's ability to block the dopamine transporter (DAT) is crucial for its reinforcing effects. However the brain functional consequences of DAT blockade by cocaine are less clear since they are confounded by its concomitant blockade of norepinephrineand serotonin transporters. To separate the dopaminergic from the non-dopaminergic effects of cocaine on brain function we compared the regional brain metabolic responses to cocaine between dopamine transporter deficient (DAT(-/-)) mice with that of their DAT(+/+) littermates. We measured regional brain metabolism (marker of brain function) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) and microPET (muPET) before and after acute cocaine administration (i.p. 10 mg/kg). Scans were conducted 2 weeks apart. At baseline DAT(-/-) mice had significantly greater metabolism in thalamus and cerebellum than DAT(+/+). Acute cocaine decreased whole brain metabolismand this effect was greater in DAT(+/+) (15%) than in DAT(-/-) mice (5%). DAT(+/+) mice showed regional decreases in the olfactory bulb, motor cortex, striatum, hippocampus, thalamus and cerebellum whereas DAT(-/-) mice showed decreases only in thalamus. The differential pattern of regional responses to cocaine in DAT(-/-) and DAT(+/+) suggests that most of the brain metabolic changes from acute cocaine are due to DAT blockade. Cocaine-induced decreases in metabolism in thalamus (region with dense noradrenergic innervation) in DAT(-/-) suggest that these were mediated by cocaine's blockade of norepinephrine transporters. The greater baseline metabolism in DAT(-/-) than DAT(+/+) mice in cerebellum (brain region mostly devoid of DAT) suggests that dopamine indirectly regulates activity of these brain regions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286542      PMCID: PMC2681086          DOI: 10.1002/syn.20503

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  34 in total

1.  Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.

Authors:  V Fauchey; M Jaber; M G Caron; B Bloch; C Le Moine
Journal:  Eur J Neurosci       Date:  2000-01       Impact factor: 3.386

2.  Exposure to appetitive food stimuli markedly activates the human brain.

Authors:  Gene-Jack Wang; Nora D Volkow; Frank Telang; Millard Jayne; Jim Ma; Manlong Rao; Wei Zhu; Christopher T Wong; Naomi R Pappas; Allan Geliebter; Joanna S Fowler
Journal:  Neuroimage       Date:  2004-04       Impact factor: 6.556

3.  Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.

Authors:  I Sora; F S Hall; A M Andrews; M Itokawa; X F Li; H B Wei; C Wichems; K P Lesch; D L Murphy; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

4.  In vivo comparative imaging of dopamine D2 knockout and wild-type mice with (11)C-raclopride and microPET.

Authors:  Panayotis K Thanos; Nicholas B Taintor; David Alexoff; Paul Vaska; Jean Logan; David K Grandy; Yuan Fang; Jing-Huei Lee; Joanna S Fowler; Nora D Volkow; Marcelo Rubinstein
Journal:  J Nucl Med       Date:  2002-11       Impact factor: 10.057

5.  Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.

Authors:  E Carboni; C Spielewoy; C Vacca; M Nosten-Bertrand; B Giros; G Di Chiara
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

6.  Differential effects of cocaine on local cerebral glucose utilization in the mouse and in the rat.

Authors:  A Zocchi; G Conti; F Orzi
Journal:  Neurosci Lett       Date:  2001-06-29       Impact factor: 3.046

7.  Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.

Authors:  Christopher T Whitlow; Cory S Freedland; Linda J Porrino
Journal:  Psychopharmacology (Berl)       Date:  2002-03-22       Impact factor: 4.530

Review 8.  Monoamine transporters: from genes to behavior.

Authors:  Raul R Gainetdinov; Marc G Caron
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-09-17       Impact factor: 13.820

Review 9.  Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder.

Authors:  Davide Viggiano; Lucia A Ruocco; Adolfo G Sadile
Journal:  Neurosci Biobehav Rev       Date:  2003-11       Impact factor: 8.989

10.  Metabolic mapping of the effects of cocaine during the initial phases of self-administration in the nonhuman primate.

Authors:  Linda J Porrino; David Lyons; Mack D Miller; Hilary R Smith; David P Friedman; James B Daunais; Michael A Nader
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

View more
  23 in total

1.  Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.

Authors:  Michael Michaelides; Javier Pascau; Juan-Domingo Gispert; Foteini Delis; David K Grandy; Gene-Jack Wang; Manuel Desco; Marcelo Rubinstein; Nora D Volkow; Panayotis K Thanos
Journal:  Eur J Neurosci       Date:  2010-07-16       Impact factor: 3.386

2.  Quantitative pharmacologic MRI: mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice.

Authors:  Teodora-Adriana Perles-Barbacaru; Daniel Procissi; Andrey V Demyanenko; F Scott Hall; George R Uhl; Russell E Jacobs
Journal:  Neuroimage       Date:  2010-12-23       Impact factor: 6.556

3.  β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors.

Authors:  Lauren M Slosky; Yushi Bai; Krisztian Toth; Caroline Ray; Lauren K Rochelle; Alexandra Badea; Rahul Chandrasekhar; Vladimir M Pogorelov; Dennis M Abraham; Namratha Atluri; Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Patrick Maloney; Hong Yuan; Zibo Li; William C Wetsel; Anthony B Pinkerton; Lawrence S Barak; Marc G Caron
Journal:  Cell       Date:  2020-05-28       Impact factor: 41.582

Review 4.  HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

Authors:  Bianca Cotto; Kalimuthusamy Natarajanseenivasan; Dianne Langford
Journal:  Prog Neurobiol       Date:  2019-05-18       Impact factor: 11.685

5.  Cocaine and methamphetamine induce opposing changes in BOLD signal response in rats.

Authors:  Saeid Taheri; Zhu Xun; Ronald E See; Jane E Joseph; Carmela M Reichel
Journal:  Brain Res       Date:  2016-04-18       Impact factor: 3.252

6.  Large-Scale, Ion-Current-Based Proteomic Investigation of the Rat Striatal Proteome in a Model of Short- and Long-Term Cocaine Withdrawal.

Authors:  Shichen Shen; Xiaosheng Jiang; Jun Li; Robert M Straubinger; Mauricio Suarez; Chengjian Tu; Xiaotao Duan; Alexis C Thompson; Jun Qu
Journal:  J Proteome Res       Date:  2016-04-11       Impact factor: 4.466

7.  Trajectory of adolescent cannabis use on addiction vulnerability.

Authors:  Yasmin L Hurd; Michael Michaelides; Michael L Miller; Didier Jutras-Aswad
Journal:  Neuropharmacology       Date:  2013-08-14       Impact factor: 5.250

Review 8.  The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.

Authors:  Helen Fox; Rajita Sinha
Journal:  Adv Pharmacol       Date:  2014

9.  Active immunotherapy for the Treatment of Cocaine Dependence.

Authors:  Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Drugs Future       Date:  2010-04-01       Impact factor: 0.148

Review 10.  Gene expression in the addicted brain.

Authors:  Zhifeng Zhou; Mary-Anne Enoch; David Goldman
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.